Study of Anti-HIV Therapy Intensification [clinicaltrials:NCT00034086]
Study of Anti-HIV Therapy Intensification [clinicaltrials:NCT00034086]
Bio2RDF identifier
NCT00034086
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00034086
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The purpose of this stu ...... levels of HIV in their blood.
brief title [clinicaltrials_vocabulary:brief-title]
Study of Anti-HIV Therapy Intensification
completion date [clinicaltrials_vocabulary:completion-date]
2006-06-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
ACTG 315 and its follow ...... screening and Week
48.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
enrollment [clinicaltrials_vocabulary:enrollment]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-04-22T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
CD4 Lymphocyte Count
HIV Protease Inhibitors
Haemophilus Vaccines
OspA Protein
Pneumococcal Vaccines
tenofovir disoproxil
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-05-17T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00034086
official title [clinicaltrials_vocabulary:official-title]
Immunologic Consequences of An ...... ollow-Up Study to ACTG 315/375
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
responsible party [clinicaltrials_vocabulary:responsible-party]
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-05-01T00:00:00Z
identifier
clinicaltrials:NCT00034086
title
Study of Anti-HIV Therapy Intensification
@en
type
label
Study of Anti-HIV Therapy Intensification [clinicaltrials:NCT00034086]
@en